Project Grant HT94252411037
Award Date
11/1/24
Completion Date
10/31/28
Dollars Obligated
$1.3M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Seattle, WA 98109, USA
Similar Awards
This federal Project Grant award from the Department of the Army Medical Command, under the Military Medical Research and Development (CFDA 12.420) program, provides $5,149,107 to the Fred Hutchinson Cancer Center in Seattle, Washington to conduct research on defining human correlates of super-evasive disseminated tumor cells, their pathological relevance, and methods to eradicate them. The 4-year award, commencing on July 1, 2025 and concluding on June 30, 2029, will support the center's...
The federal Project Grant award of $2,288,000.00 was issued by the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) to the Fred Hutchinson Cancer Center in Seattle, Washington. The award supports advanced biomedical research focused on transforming healthcare for military service members and the general public, with a specific focus on targeting epidermal plasticity to prevent triple negative breast cancer. The research will be...
This $175,978 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) is funding research by the Fred Hutchinson Cancer Center, doing business as the Seattle Cancer Care Alliance, to study the role of ARID1A mutations in intrahepatic cholangiocarcinoma. The award period is from August 1, 2024 to July 31, 2026. The funding will support the organization's biomedical research and provision of medical care services related to...
The University of Washington received a $622,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on the fibrolamellar carcinoma tumor microenvironment using human tumor slice cultures. The award has a performance period from July 1, 2024 to June 30, 2026. Through this funding, the University of Washington will investigate innovative approaches to improve understanding of the fibrolamellar carcinoma tumor...
This $11.7 million cooperative agreement from the Department of the Army Medical Command will fund research from August 1, 2022 to July 31, 2026 under the Military Medical Research and Development program (CFDA 12.420). The Fred Hutchinson Cancer Center will work with sub-awardees the University of Washington and The Washington University to prevent lethal metastatic breast cancer. Specifically, the recipients will identify and eradicate clinically relevant disseminated tumor cells by recruiting...
The Defense Health Agency awarded a $1,412,826 Project Grant on September 1, 2023 to Beth Israel Deaconess Medical Center, Inc. (Bidmc) to conduct research through the Military Medical Research and Development (CFDA 12.420) program. The grant, titled "Identification of Risk and Early Detection Biomarkers for Liver Cancer," will support a 3-year study led by Dr. Towia Libermann at Bidmc, with a sub-award to Vanderbilt University Medical Center (VUMC) to assist with case...
The University of Washington was awarded a $1,407,738 federal Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to enhance immunity in colorectal cancer liver metastases. The award has a performance period from August 1, 2024 to July 31, 2028. Additionally, the University of Washington provided a $189,043 sub-grant to the Fred Hutchinson Cancer Center, doing business as the Seattle Cancer Care Alliance, to contribute...
The federal Project Grant award of $1,578,836.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports the Fred Hutchinson Cancer Center (doing business as Seattle Cancer Care Alliance) in developing and exploiting a third-generation prostate cancer dependency map to identify cancer vulnerabilities and treatment targets. The award, which runs from August 1, 2024 to July 31, 2027, will enable the research organization to conduct innovative...
The Defense Health Agency awarded a $528,000 Project Grant to the Fred Hutchinson Cancer Center, doing business as the Seattle Cancer Care Alliance, to assess the landscape of cell surface targets in metastatic prostate cancer. This 2-year grant, which began on April 15, 2024, is funded through the Military Medical Research and Development program (CFDA 12.420). The project aims to advance biomedical research on innovative therapeutic approaches for cancer, in line with the program's goals of...
The Fred Hutchinson Cancer Research Center was awarded a $1,125,843 Project Grant from the Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420) for the period of August 1, 2021 through July 31, 2024. Under this award, Fred Hutchinson Cancer Research Center will define and modulate BRCANESS to improve the precision of prostate cancer therapy. The Military Medical Research and Development program supports biomedical research to transform military...